Top Markets
#1 Cortex Cortex +174.36%
#2 GEKKO GEKKO +51.79%
#3 ADO Protocol ADO Protocol +18.52%
#4 o1.exchange o1.exchange +10.89%
#5 Official Trump Official Trump +10.62%
#6 Audiera Audiera +10.49%
#7 Status Status +10.19%
#8 aelf aelf +9.22%
#9 DAPPOS DAPPOS +8.11%
#10 Seeker Seeker +6.62%
Coin of the day
Cortex Cortex
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Rangering i aksjer #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Aksjekurs
$59.98
Sist synkronisert: 2024-12-13
Markedsverdi
$1.22B
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Longboard Pharmaceuticals, Inc. (LBPH)

Kategori

Healthcare
Inntekter for Longboard Pharmaceuticals, Inc. (LBPH)
Inntekter i Sep 2024 TTM: $-76.34M
Ifølge Longboard Pharmaceuticals, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat $-76.34M. I 2022 hadde selskapet et resultat på $-43.95M, en nedgang sammenlignet med resultatet i 2021, som var $-27.80M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Longboard Pharmaceuticals, Inc. fra 2020 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $-76.34M 40.28%
2023 $-54.42M 23.84%
2022 $-43.95M 58.09%
2021 $-27.80M 93.03%
2020 $-14.40M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -7,009.38%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -2,655.08%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B 5,160.66%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B 3,943.54%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH